The options for medipharm will look pretty good if it continues progress. I hope they wont be slack with updates for fire & flower
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025